Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1451
Chatham Lodging
CLDT
$348M
| $11.6K | ﹤0.01% |
1,408
-20,783
| -94% | -$171K |
|
1452
Precigen
PGEN
$1.13B
| $11.4K | ﹤0.01% |
+7,536
| New | +$11.4K |
|
|
OLP
1453
One Liberty Properties
OLP
$494M
| $11.3K | ﹤0.01% |
+490
| New | +$11.3K |
|
1454
Pacific Biosciences
PACB
$351M
| $11.1K | ﹤0.01% |
8,131
-1,327,731
| -99% | -$1.81M |
|
|
PKST
1455
Peakstone Realty Trust
PKST
$519M
| $10.9K | ﹤0.01% |
+1,047
| New | +$10.9K |
|
1456
Anavex Life Sciences
AVXL
$805M
| $10.8K | ﹤0.01% |
2,527
-52,323
| -95% | -$224K |
|
1457
Zillow
ZG
$20.4B
| $10.8K | ﹤0.01% |
+238
| New | +$10.8K |
|
1458
Autoliv
ALV
$9.68B
| $10.6K | ﹤0.01% |
+100
| New | +$10.6K |
|
1459
Cabaletta Bio
CABA
$168M
| $10.6K | ﹤0.01% |
1,441
-10,539
| -88% | -$77.4K |
|
1460
Lyell Immunopharma
LYEL
$246M
| $10.5K | ﹤0.01% |
+381
| New | +$10.5K |
|
1461
Phibro Animal Health
PAHC
$1.61B
| $10.4K | ﹤0.01% |
+607
| New | +$10.4K |
|
1462
Tourmaline Bio
TRML
$1.22B
| $10.1K | ﹤0.01% |
+766
| New | +$10.1K |
|
1463
Vanda Pharmaceuticals
VNDA
$266M
| $10.1K | ﹤0.01% |
1,738
-26,130
| -94% | -$152K |
|
1464
Liberty Live Group Series C
LLYVK
$9.23B
| $10K | ﹤0.01% |
+274
| New | +$10K |
|
1465
Xeris Biopharma Holdings
XERS
$1.21B
| $10K | ﹤0.01% |
+4,426
| New | +$10K |
|
1466
ALX Oncology
ALXO
$56.8M
| $9.07K | ﹤0.01% |
1,555
-9,382
| -86% | -$54.7K |
|
|
AMK
1467
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $8.91K | ﹤0.01% |
258
-11,601
| -98% | -$401K |
|
1468
Zentalis Pharmaceuticals
ZNTL
$107M
| $8.9K | ﹤0.01% |
2,120
-29,467
| -93% | -$124K |
|
1469
Nautilus Biotechnolgy
NAUT
$91M
| $8.53K | ﹤0.01% |
+3,740
| New | +$8.53K |
|
1470
Atea Pharmaceuticals
AVIR
$249M
| $8.5K | ﹤0.01% |
2,515
-27,950
| -92% | -$94.5K |
|
|
CBL
1471
CBL Properties
CBL
$993M
| $8.49K | ﹤0.01% |
372
-11,456
| -97% | -$261K |
|
|
AMRN
1472
Amarin Corp
AMRN
$310M
| $8.37K | ﹤0.01% |
597
-2,756
| -82% | -$38.6K |
|
1473
PagSeguro Digital
PAGS
$2.78B
| $8.28K | ﹤0.01% |
708
-276,160
| -100% | -$3.23M |
|
1474
MeiraGTx Holdings
MGTX
$612M
| $8.12K | ﹤0.01% |
1,920
-12,457
| -87% | -$52.7K |
|
|
RVNC
1475
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.04K | ﹤0.01% |
3,118
-34,500
| -92% | -$89K |
|